Tilray Brands
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tilray Brands and other ETFs, options, and stocks.About TLRY
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness.
TLRY Key Statistics
TLRY News
Temporarily profitable Tilray is taking advantage of its chance to raise some cash. Tilray Brands (TLRY -15.95%), the Canadian marijuana stock, closed 22% high...
Tilray ( (TLRY) ) has released its Q1 earnings. Here is a breakdown of the information Tilray presented to its investors. Elevate Your Investing Strategy: Tak...
Tilray ((TLRY)) has held its Q1 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...
Analyst ratings
60%
of 10 ratingsMore TLRY News
Tilray Brands (TLRY) remains unprofitable, recording losses that have increased at an average annual rate of 31.4% over the past five years. The company is not...
Image source: The Motley Fool. Thursday, October 9, 2025 at 8:30 a.m. ET Call participants Chairman and Chief Executive Officer — Irwin Simon Chief Financia...
Investors in Tilray Brands Inc (Symbol: TLRY) saw new options begin trading today, for the November 28th expiration. At Stock Options Channel , our YieldBoost f...
Tilray surprised marijuana investors once today. Can it do it again? Tilray Brands (TLRY 25.29%) stock exploded higher after reporting a surprise profit in its...
Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings. The company...
Reports Q1 revenue $209.5M, consensus $205.75M. Irwin Simon, CEO, stated, “As we enter fiscal 2026, Tilray’s (TLRY) first quarter results underscore the effecti...
Tilray Brands (TLRY) shares slipped ahead of Thursday’s earnings release as investors turned cautious following a string of weak analyst ratings and mixed finan...